Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-26 @ 12:41 AM
Study NCT ID:
NCT00278460
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2006-01-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-11
Start Date Type:
None
Primary Completion Date:
2006-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-16
First Submit QC Date:
None
Study First Post Date:
2006-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-18
Last Update Post Date:
2017-01-19
Last Update Post Date Type:
ESTIMATED